AGP Executive Report
Last update: 11 hours agoPancreatic cancer breakthrough: Dana-Farber–led results at ASCO highlight daraxonrasib (RASolute 302), an experimental pill that targets RAS via cyclophilin A, nearly doubling survival versus chemotherapy in metastatic pancreatic cancer. Neurogenetics in aging: A Boston University study finds transposons—normally quiet DNA elements—become more active in the brain with age, producing new RNA patterns that may relate to neurodegeneration. Sleep apnea drug angle: A new review argues carbonic anhydrase inhibitors could help obstructive sleep apnea by addressing underappreciated breathing-control mechanisms beyond airway collapse. Local science & health training: UMass Chan Medical School held its 53rd commencement, emphasizing medicine’s “humanity” alongside clinical training. Boston-area STEM moment: NASA confirmed a meteor caused the “double boom” that shook New England, with energy estimated at about 300 tons of TNT. Robotics leadership shakeup: Boston Dynamics is set to lose its top AI robotics researcher to Google DeepMind, adding to a broader talent exodus. Healthcare costs debate: A report argues hospital consolidation is driving up prices by reducing competition, challenging claims that mergers lower costs.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
